This is the fourth in a series examining key Buffalo Bills position groups - what happened in 2025 and what could change in 2026. This installment is on the defensive line. You’ve probably seen the ...

In an X post, Cramer suggested Saylor issue a zero-coupon convertible bond to limit Bitcoin’s downside at $73,802, a level he described as the “line in the sand.” “Strategy’s earnings depend upon it, ...

California man arrested after fortified underground bunker found with weapons cache How accurate is Punxsutawney Phil? See his prediction history. US health officials monitor deadly virus Why the NFL ...

Michigan football is entering a new era, but if all goes to plan, it won't look incredibly different from the era that the Wolverines are coming off of -- of course, meaning the end of Jim Harbaugh's ...

The nine justices on the U.S. Supreme Court have many duties to perform — most of them important, and at least one that appears to be silly but necessary. Sometimes, duty requires reminding judges on ...

The doll features several additions that align with the experiences of autistic people. Mattel has released a new Barbie doll that serves a unique purpose, representing those on the autism spectrum.

FASHION 3431, CRUSHING CAROLINA’S SEASON. IOWA STATE IS 15 AND ZERO FOR THE FIRST TIME EVER, AND WE NEEDED TO GET A VIBE. CHECK HERE ON TJ OTZELBERGER. SEEMS LIKE HE’S DOING WELL HIMSELF. SEEMS LIKE ...

Syracuse, N.Y. -- The Onondaga County Water Authority will spend the weekend getting ready to repair a ruptured transmission line on Monday as work crews and equipment stream in from as far as Texas.

After AstraZeneca and Daiichi Sankyo made waves in June with eye-opening results for Enhertu in a combination treatment for a particular type of breast cancer, the companies have scored an FDA ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

Pfizer has rolled out detailed trial data suggesting Tukysa could be part of a new first-line treatment to delay the progression of HER2-positive breast cancer. The current standard of care for the ...